NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 313 filers reported holding NOVOCURE LTD in Q4 2022. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $398,187 | +15.3% | 6,621 | +40.6% | 0.01% | 0.0% |
Q4 2022 | $345,479 | +28.0% | 4,710 | +31.0% | 0.01% | +44.4% |
Q3 2022 | $270,000 | -20.8% | 3,595 | -20.9% | 0.01% | 0.0% |
Q4 2021 | $341,000 | +8.6% | 4,546 | +68.2% | 0.01% | 0.0% |
Q3 2021 | $314,000 | -9.8% | 2,702 | +72.2% | 0.01% | -18.2% |
Q2 2021 | $348,000 | +10.1% | 1,569 | -34.4% | 0.01% | 0.0% |
Q1 2021 | $316,000 | -28.2% | 2,393 | -5.9% | 0.01% | -38.9% |
Q4 2020 | $440,000 | – | 2,542 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |